BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16306615)

  • 1. Activation of the ATR pathway by human immunodeficiency virus type 1 Vpr involves its direct binding to chromatin in vivo.
    Lai M; Zimmerman ES; Planelles V; Chen J
    J Virol; 2005 Dec; 79(24):15443-51. PubMed ID: 16306615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.
    Zimmerman ES; Chen J; Andersen JL; Ardon O; Dehart JL; Blackett J; Choudhary SK; Camerini D; Nghiem P; Planelles V
    Mol Cell Biol; 2004 Nov; 24(21):9286-94. PubMed ID: 15485898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of mobile chromatin-associated nuclear foci containing HIV-1 Vpr and VPRBP is critical for the induction of G2 cell cycle arrest.
    Belzile JP; Abrahamyan LG; GĂ©rard FC; Rougeau N; Cohen EA
    PLoS Pathog; 2010 Sep; 6(9):e1001080. PubMed ID: 20824083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo.
    Zimmerman ES; Sherman MP; Blackett JL; Neidleman JA; Kreis C; Mundt P; Williams SA; Warmerdam M; Kahn J; Hecht FM; Grant RM; de Noronha CM; Weyrich AS; Greene WC; Planelles V
    J Virol; 2006 Nov; 80(21):10407-18. PubMed ID: 16956949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Vpr in HIV-1 disease progression is independent of its G2 arrest induction function.
    Lai M; Chen J
    Cell Cycle; 2006 Oct; 5(19):2275-80. PubMed ID: 16969134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ataxia telangiectasia-mutated and Rad3-related protein is dispensable for retroviral integration.
    Dehart JL; Andersen JL; Zimmerman ES; Ardon O; An DS; Blackett J; Kim B; Planelles V
    J Virol; 2005 Feb; 79(3):1389-96. PubMed ID: 15650165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATR and GADD45alpha mediate HIV-1 Vpr-induced apoptosis.
    Andersen JL; Zimmerman ES; DeHart JL; Murala S; Ardon O; Blackett J; Chen J; Planelles V
    Cell Death Differ; 2005 Apr; 12(4):326-34. PubMed ID: 15650754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.
    Terada Y; Yasuda Y
    Mol Cell Biol; 2006 Nov; 26(21):8149-58. PubMed ID: 16923959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT.
    Andersen JL; DeHart JL; Zimmerman ES; Ardon O; Kim B; Jacquot G; Benichou S; Planelles V
    PLoS Pathog; 2006 Dec; 2(12):e127. PubMed ID: 17140287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphatase type 2A-dependent and -independent pathways for ATR phosphorylation of Chk1.
    Li G; Elder RT; Qin K; Park HU; Liang D; Zhao RY
    J Biol Chem; 2007 Mar; 282(10):7287-98. PubMed ID: 17210576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R.
    Roshal M; Kim B; Zhu Y; Nghiem P; Planelles V
    J Biol Chem; 2003 Jul; 278(28):25879-86. PubMed ID: 12738771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombination.
    Nakai-Murakami C; Shimura M; Kinomoto M; Takizawa Y; Tokunaga K; Taguchi T; Hoshino S; Miyagawa K; Sata T; Kurumizaka H; Yuo A; Ishizaka Y
    Oncogene; 2007 Jan; 26(4):477-86. PubMed ID: 16983346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural alteration of DNA induced by viral protein R of HIV-1 triggers the DNA damage response.
    Iijima K; Kobayashi J; Ishizaka Y
    Retrovirology; 2018 Jan; 15(1):8. PubMed ID: 29338752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage response.
    Ward J; Davis Z; DeHart J; Zimmerman E; Bosque A; Brunetta E; Mavilio D; Planelles V; Barker E
    PLoS Pathog; 2009 Oct; 5(10):e1000613. PubMed ID: 19798433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest.
    Belzile JP; Richard J; Rougeau N; Xiao Y; Cohen EA
    J Virol; 2010 Apr; 84(7):3320-30. PubMed ID: 20089662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.
    Yoshizuka N; Yoshizuka-Chadani Y; Krishnan V; Zeichner SL
    J Virol; 2005 Sep; 79(17):11366-81. PubMed ID: 16103188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25.
    Elder RT; Yu M; Chen M; Zhu X; Yanagida M; Zhao Y
    Virology; 2001 Sep; 287(2):359-70. PubMed ID: 11531413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex.
    Popov S; Rexach M; Zybarth G; Reiling N; Lee MA; Ratner L; Lane CM; Moore MS; Blobel G; Bukrinsky M
    EMBO J; 1998 Feb; 17(4):909-17. PubMed ID: 9463369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infected patients.
    Kino T; De Martino MU; Charmandari E; Ichijo T; Outas T; Chrousos GP
    Diabetes; 2005 Jan; 54(1):23-31. PubMed ID: 15616007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus type 1 vpr protein transactivation function: mechanism and identification of domains involved.
    Forget J; Yao XJ; Mercier J; Cohen EA
    J Mol Biol; 1998 Dec; 284(4):915-23. PubMed ID: 9837715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.